antiviral
Two recently authorized antiviral drugs designed to protect against the most severe outcomes of COVID-19 may be game-changers during the ongoing pandemic. Those benefits may come at a cost, however. It’s crucial that you and your healthcare providers understand these drugs’ potential side effects, so you use them as safely…
Early in 2022, the FDA granted emergency use authorization to two antiviral drugs to treat COVID-19: Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir). These treatments aren’t 100% effective, though they are more effective the sooner they’re prescribed, so it’s been crucial for scientists to continue to study other drugs and…
When the pandemic first broke out in 2020, every COVID-19 treatment was experimental. Researchers tested existing drugs, like the antiparasitic Plaquenil (hydroxychloroquine) or the anti-inflammatory Ozurdex, Maxidex or others (dexamethasone), that they hoped could fight the virus or dampen damaging inflammation. Other medical personnel tried antidepressants on patients. Now, two…
Good morning, all. We hope you’re hanging tough and that your week is off to a splendid start. As for the news cycle — things could be better. A new study on a medication used to treat COVID-19 contradicts its efficacy, and another pharmaceutical company recalled a batch of Metformin….
While much of the focus for potential COVID-19 treatments has been on drugs that were either created or under development in the United States, one drug, Avigan (favipiravir), which was developed in Japan, is drawing attention.
Certain medications can cause harm to your kidneys. Find out which ones they are, how you can avoid side effects and possible alternatives.
